Nuvve Seeks Shareholder Approval for Reverse Split, Massive Dilution, and Change of Control

summarizeSummary

Nuvve Holding Corp. is asking shareholders to approve a reverse stock split to avoid delisting and a deal with Omnia that will lead to a change of control and over 1000% potential dilution for existing shareholders.

check_boxKey Events · Corporate Governance and Compliance · NVVE

• Proposed Reverse Stock Split

  The Board seeks approval for a reverse stock split in a range of 1-for-2 to 1-for-40 to regain Nasdaq compliance, following a delisting notice and prior cumulative 1-for-400 reverse splits.

• Massive Potential Dilution

  Shareholders are asked to approve the issuance of up to 96.8 million new shares in connection with the Omnia Venture Agreements, representing over 1000% potential dilution to current outstanding shares.

• Change of Control

  The Omnia Issuance will result in Omnia and its affiliates owning a majority of the voting power of the company's common stock upon conversion of Series B Preferred Stock.

• Premium Conversion Price for Preferred Stock

  The Series B Preferred Stock, part of the Omnia deal, is convertible into common stock at a price of $1.25 per share, a significant premium to the current market price of $0.3552.

auto_awesomeAnalysis · NVVE · Manufacturing

Nuvve Holding Corp. is seeking shareholder approval for two critical proposals that will fundamentally reshape the company. The first is a reverse stock split, ranging from 1-for-2 to 1-for-40, aimed at regaining Nasdaq compliance after receiving a delisting notice. This follows a history of prior reverse splits (cumulative 1-for-400 in the last two years), indicating severe and persistent challenges in maintaining its listing. The second, and more impactful, proposal is the issuance of shares related to the Omnia Venture Agreements. This deal, if approved, will result in a change of control, with Omnia and its affiliates gaining majority voting power. Furthermore, it involves the potential issuance of up to 96.8 million new shares, representing over 1000% dilution to existing shareholders, despite a conversion price of $1.25 per share which is a significant premium to the current market price of $0.3552. The Board did not obtain a fairness opinion for this transaction, citing cost and time, which is a notable concern given the magnitude of the deal and the company's 'going concern' warning.